Survey of Customers Requesting Medical Information: Preferences and Information Needs of Patients and Health Care Professionals to Support Treatment Decisions

Fung, Stacey M.; Sud, Cheryl; Suchodolski, Matthew

doi:10.1007/s43441-019-00031-3

Cited by 5 publications

(7 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The information was used by clinicians to enhance patient care specifically in areas of patient education (72%) and dosing clarification (53%). Fung et al 6 saw similar responses that drug information helped guide discussions with patients (32%-50%) as well as used for the clinician's own education (42%-56%). Understanding how other clinicians use company drug information can assist the practitioner to understand another resource that may be useful when faced with a similar situation.…”

Section: Discussionmentioning

confidence: 93%

“…Pharmaceutical companies' Medical Information services routinely conduct customer satisfaction surveys when a response to an unsolicited question is provided. 6,11 These surveys usually just assess satisfaction or preferences in the manner that content is received but not the impact of the information in clinical care. 11 This assessment was made, however, by Fung et al, 6 who surveyed 192 health care professionals, including 25 NPs, who had requested information from the Medical Information services of 4 pharmaceutical companies.…”

Section: Background and Significancementioning

confidence: 99%

“…6,11 These surveys usually just assess satisfaction or preferences in the manner that content is received but not the impact of the information in clinical care. 11 This assessment was made, however, by Fung et al, 6 who surveyed 192 health care professionals, including 25 NPs, who had requested information from the Medical Information services of 4 pharmaceutical companies. The health care professionals, depending on specialty and classification, indicated that the drug information they received led to treatment management for patients (30%-64%), led to deciding to prescribe a medicine (23%-60%), helped guide discussions with patients (32%e50%), was used for future treatment decisions/discussion (35%-51%), or was used for selfeducation (42%-66%).…”

Section: Background and Significancementioning

confidence: 99%

“…4 In the US, Medical Information services are an integral part of the medical affairs function of the industry and are typically staffed with health care professionals, including nurses, pharmacists, and physicians, as well as life science PhDs. 5,6…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Enhancing Patient Care: Value of Pharmaceutical Medical Information Services

Albano¹,

Follman²,

Patel³

et al. 2021

The Journal for Nurse Practitioners

View full text Add to dashboard Cite

Information concerning medications is a necessity for nurse practitioners and other clinicians. Pharmaceutical companies' Medical Information services are an option for evidence-based, scientifically balanced information. This survey elicited clinicians' opinions regarding the use and utility of Medical Information services. The top reasons cited for not using the services included bias, awareness, and lack of transparency. Awareness of availability and quality of information from Medical Information services and addressing bias and transparency issues are needed. Clinicians who requested information from Medical Information services indicated receiving high-quality and useful information that had a clinical impact or provided a patient benefit.

show abstract

Section: Discussionmentioning

confidence: 93%

Section: Background and Significancementioning

confidence: 99%

Section: Background and Significancementioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Enhancing Patient Care: Value of Pharmaceutical Medical Information Services

Albano¹,

Follman²,

Patel³

et al. 2021

The Journal for Nurse Practitioners

View full text Add to dashboard Cite

show abstract

“…Surveying approximately 200 HCPs in the USA in 2017, Fung et al explored their preferences to access such information [ 5 ]. For physicians, journal articles and internet resources were equally favoured (29% and 28%, respectively).…”

Section: Introductionmentioning

confidence: 99%

The Critical Need to Build a European Governance Model for Online Access to Medical Information Services: A Position Paper

Pienaar

Dunnett²,

Flores

et al. 2021

Pharm Med

View full text Add to dashboard Cite

European pharmaceutical companies have a legal requirement to provide non-promotional Medical Information (MI) services to support healthcare professionals (HCPs) who are using their medicinal products. While the industry has self-regulating bodies with established Codes of Practice, these mainly focus on promotional messaging and commercial activities. In the absence of similar frameworks for MI, such services struggle to understand how to meet HCP digital expectations, often in fear of breaching the promotional codes. This is limiting access to the wealth of non-promotional patient-focussed information held within the industry. Meanwhile, a large volume of unregulated, low-quality information can be readily found on the internet. To understand the current status, the Medical Information Leaders in Europe (MILE) industry association performed a benchmarking survey which explored the online MI service provision of 13 mid-large pharmaceutical companies across Europe. This highlighted a great diversity in approach in terms of geographical coverage and content. Visibility and access for HCPs is complex, compromising online engagement and website utilisation. This MILE position paper highlights the critical need to establish a clear governance model, which empowers pharmaceutical company MI functions to provide unbranded, non-promotional, medicinal product information sources to support HCP online information needs. It is essential to build confidence, transparency and trust by establishing a practical quality framework with principles and standards for online MI services for HCPs. Key PointsCurrently, there is no specific framework governing the provision of online medical information by the pharmaceutical industry for healthcare professionals (HCPs) in Europe.

show abstract